Home  »  Industry   »  Meeting and exceeding analyst predictions: Spectru...

Meeting and exceeding analyst predictions: Spectrum Pharmaceuticals Inc. (SPPI)

At the end of the latest market close, Spectrum Pharmaceuticals Inc. (SPPI) was valued at $0.84. In that particular session, Stock kicked-off at the price of $0.8199 while reaching the peak value of $0.8689 and lowest value recorded on the day was $0.815. The stock current value is $0.89.Recently in News on July 29, 2022, Spectrum Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update. Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the second quarter 2022 financial results and provide a corporate update on Thursday, August 11, 2022 at 8:30 a.m. Eastern/5:30 a.m. Pacific. You can read further details here

Spectrum Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.6200 on 01/03/22, with the lowest value was $0.6000 for the same time period, recorded on 01/27/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Spectrum Pharmaceuticals Inc. (SPPI) full year performance was -74.30%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Spectrum Pharmaceuticals Inc. shares are logging -72.70% during the 52-week period from high price, and 48.35% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.60 and $3.26.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1570096 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Spectrum Pharmaceuticals Inc. (SPPI) recorded performance in the market was -34.24%, having the revenues showcasing -2.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 155.93M, as it employees total of 163 workers.

Specialists analysis on Spectrum Pharmaceuticals Inc. (SPPI)

During the last month, 0 analysts gave the Spectrum Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.9007, with a change in the price was noted +0.14. In a similar fashion, Spectrum Pharmaceuticals Inc. posted a movement of +17.10% for the period of last 100 days, recording 2,248,210 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SPPI is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Spectrum Pharmaceuticals Inc. (SPPI)

Raw Stochastic average of Spectrum Pharmaceuticals Inc. in the period of last 50 days is set at 85.21%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 100.00%. In the last 20 days, the company’s Stochastic %K was 71.74% and its Stochastic %D was recorded 63.63%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -34.24%. Additionally, trading for the stock in the period of the last six months notably improved by 19.08%, alongside a downfall of -74.30% for the period of the last 12 months. The shares increased approximately by 2.28% in the 7-day charts and went down by 8.51% in the period of the last 30 days. Common stock shares were lifted by -2.68% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts